Authors: Hu, W Wu, WG Nash, MA Freedman, RS Kavanagh, JJ Verschraegen, CF

Citation: W. Hu et al., Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancercell lines, ANTICANC R, 20(2A), 2000, pp. 729-733

Authors: Melichar, B Nash, MA Lenzi, R Platsoucas, CD Freedman, RS

Citation: B. Melichar et al., Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3(+) tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis, CLIN EXP IM, 119(1), 2000, pp. 19-27

Authors: Nash, MA Ferrandina, G Gordinier, M Loercher, A Freedman, RS

Citation: Ma. Nash et al., The role of cytokines in both the normal and malignant ovary, ENDOCR-R CA, 6(1), 1999, pp. 93-107

Authors: Gordinier, ME Zhang, HZ Patenia, R Levy, LB Atkinson, EN Nash, MA Katz, RL Platsoucas, CD Freedman, RS

Citation: Me. Gordinier et al., Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma, CLIN CANC R, 5(9), 1999, pp. 2498-2505

Authors: Loercher, AE Nash, MA Kavanagh, JJ Platsoucas, CD Freedman, RS

Citation: Ae. Loercher et al., Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells, J IMMUNOL, 163(11), 1999, pp. 6251-6260

Authors: Nash, MA Loercher, AE Freedman, RS

Citation: Ma. Nash et al., In vitro growth inhibition of ovarian cancer cells by decorin: Synergism of action between decorin and carboplatin, CANCER RES, 59(24), 1999, pp. 6192-6196